增强版参与者信息手册与多媒体干预对改善HIV合并肥胖人群随机临床试验知情同意质量的方案:一项嵌套于试验的研究(SWAT)
本方案描述一项前瞻性、多中心、随机、对照、平行组SWAT,嵌套于SWIFT试验(研究司美格鲁肽联合饮食建议对HIV合并肥胖者减重效果)。受试者按1:1随机接受标准PIL/ICF或增强版PIL/ICF加含动画网站,主要结局为知情同意质量(改良DICCT测试),次要结局为2周后回忆得分。结果将为多媒体改善知情同意质量提供方法学证据。
要点
- 系统综述提示参与者对随机化和风险等知情同意关键概念理解常较差。
- 该SWAT将HIV合并肥胖受试者1:1随机至标准或增强版PIL/ICF加网站组。
- 主要结局为知情同意后48小时内改良DICCT评估的知情同意质量。
核心结论
- 本SWAT结果将补充多媒体用于改善随机临床试验知情同意质量的方法学证据。
研究设计与样本
- 前瞻性、多中心、随机、对照、平行组SWAT,嵌套于SWIFT试验(EudraCT:2019-002314-39)。
- SWIFT试验为前瞻性、多中心、随机、开放标签、对照试验,比较司美格鲁肽联合饮食建议与单用饮食建议对HIV合并肥胖者减重效果。
- SWAT受试者按1:1随机至对照组(标准PIL/ICF)或干预组(增强版PIL/ICF加含动画的网站)。
主要发现
- 主要结局为知情同意质量,由经验证的改良Deaconess知情同意理解测试(DICCT)评估,于宿主试验知情同意后48小时内实施。
- 次要结局为回忆,由改良DICCT问卷评分于宿主试验知情同意后2周测量。
- 增强版PIL/ICF及网站依据推广简明英语和可及性公众材料的机构指南,联合HIV倡导组织HIV Ireland及作者既往知情同意文件工作开发。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is the investigator's responsibility to communicate the relevant information about a clinical trial to participants before they provide informed consent to take part. Systematic reviews indicate that participants often have a poor understanding of the concepts which are key to ensuring valid informed consent, such as randomisation and risks/discomforts. Paper-based participant information leaflets and informed consent forms (PIL/ICFs) are becoming longer and are often too complex for many participants. Multimedia interventions and enhanced PIL/ICFs have been trialled in an attempt to improve participants' understanding of various aspects of research studies. However, there is insufficient empirical evidence to determine how effective such interventions are. This protocol describes a study to evaluate whether an enhanced PIL/ICF and website help research participants to understand important information about a human immunodeficiency virus (HIV) randomised clinical trial. METHODS: This Study Within A Trial (SWAT) is a prospective, multi-centre, randomised, controlled, parallel-group study embedded in a host clinical trial. The host trial (the SWIFT trial; EudraCT: 2019-002314-39) is a prospective, multi-centre, randomised, open-label, controlled trial investigating if semaglutide along with dietary advice assists individuals with HIV and obesity to lose weight, compared to dietary advice alone. For the SWAT, participants will be randomised in a 1:1 ratio to either the control (standard PIL/ICF) or the intervention (an enhanced PIL/ICF and a website which includes animations). The enhanced PIL/ICF and website were developed in line with the guidance from organisations which promote plain English and accessible public-facing materials in conjunction with HIV Ireland, a HIV advocacy organisation, and our previous work on consent documents. The primary outcome of the SWAT is the quality of informed consent, assessed by a validated comprehension test-the modified Deaconess Informed Consent Comprehension Test (DICCT). The DICCT will be administered within 48 h of consent to the host trial. The secondary is recall, measured by the modified DICCT questionnaire scores 2 weeks post-consent to the host trial. DISCUSSION: The results of this SWAT will add to the methodological evidence base on the use of multimedia to improve the quality of informed consent to randomised clinical trials. TRIAL REGISTRATION: ClinicalTrials.gov NCT04174755 . EudraCT 2019-002314-39. SWAT 160, Northern Ireland Hub for Trials Methodology Research SWAT repository (Clarke M, et al., Trials. 16:P209, 2015).
引用
- O'Sullivan L, Savinelli S, O'Hare S, et al. An enhanced participant information leaflet and multimedia intervention to improve the quality of informed consent to a randomised clinical trial enrolling people living with HIV and obesity: a protocol for a Study Within A Trial (SWAT). Trials. 2022. PMID: 35039057. doi:10.1186/s13063-021-05979-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。